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Davis and Chawla, 2011; Sun et al., 2014a; Menche et al., 
2015). The human “diseasome” was the first network-based 
model connecting diseases (Goh et al., 2007). The network 
was designed to associate diseases if they shared at least one 
gene, based on the Online Mendelian Inheritance in Man da-
tabase (OMIM) (Hamosh et al., 2005). Recently, Roque et al. 
(2011) created an approach to gather phenotypic descriptions 
of patients from medical records that would suggest new dis-
ease-disease associations. Although all these studies provide 
comprehensive views of links between diseases, they all rely 
on existing knowledge, i.e., genes, pathways and phenotypic 
associations (Hidalgo et al., 2009). 
Epidemiological and biological studies have suggested that 
a number of environmental chemicals may play a causative 
1  Introduction 
Although it is well established that genes and environmental 
factors influence common human diseases, understanding 
disease-causing defects is still a challenge (Hunter, 2005). 
Comorbidity, i.e., the emergence of one or more additional 
disorders co-occurring with a primary disease due to a given 
treatment, lifestyle or environmental exposure, increases the 
degree of complexity.
Identifying how diseases are connected to each other would 
improve our understanding of the etiology and pathogenesis 
of similar diseases. Several network based approaches have 
allowed deciphering disease comorbidity (Goh et al., 2007; 
Lee et al., 2008; Hidalgo et al., 2009; Suthram et al., 2010; 
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is associated with cognitive impairment and behavioral prob-
lems with a high level of evidence, whereas methoxychlor is 
associated with reduced male fertility with limited evidence. 
To develop our EDN, we took advantage of the computational 
network biology approach that we developed previously with 
toxicogenomics data (Audouze et al., 2010). The concept, 
originally based on Protein-Protein Associations Network 
(P-PAN), can be transposed to other areas of application and 
has shown success with experimental validation of novel as-
sociations between chemicals and biological targets (Audouze 
et al., 2014). Although the list of chemicals and disease asso-
ciations in the TDDB database is far from complete, it has the 
advantage of having three evidence layers. Therefore, instead 
of limiting ourselves to “binary” information (i.e., presence 
versus absence of chemical-disease associations), we have the 
opportunity to include some “weight” in the association and so 
to go beyond the bipartite network-based approach (Lee et al., 
2008). Here we also present a case study to demonstrate the 
ability of our EDN model to predict disease-disease connec-
tions, chemical-disease links, and potential new associations. 
To our knowledge, this is the first time that a disease comor-
bidity network based on environmental chemicals has been 
developed using several layers of evidence.
2  Materials and methods
Data set
We extracted chemical-disease associations from the publicly 
available TDDB database (as of April 2015). The database 
contains information on 2790 connections between 601 en-
vironmental chemicals and 198 human diseases. We used the 
three available strengths of evidence to create a three-level dis-
ease network: The “strong evidence” (SE) represents a verified 
link between a chemical and a disease. Three cases fall under 
this category: (a) the chemical toxicity is well known and the 
chemical is recognized to cause the disease, (b) the causal 
associations have been found in recent, large, prospective or 
retrospective cohort studies, and (c) the chemicals are listed 
as group 1 human carcinogens by the International Agency for 
Research on Cancer (IARC)2. 
The “good evidence” (GE) includes chemical-disease asso-
ciations based on epidemiological studies, chemicals listed in 
the IARC group 2A2 (limited evidence for humans and strong 
for animal – probably carcinogenic) and chemicals listed by 
OEHHA’s Prop 65 program3. 
Finally, the “limited evidence” (LE) category contains 
chemicals associated with diseases based on case reports, on 
conflicting evidence, and chemicals listed in the IARC group 
2B2 and the EPA group B24 (limited evidence in humans and 
in animals – possibly carcinogenic). Although the extracted 
data may be limited, the TDDB database represents the most 
role in some human disorders. However, humans are poten-
tially exposed to more than 80,000 substances for which little 
toxicity information exists. During recent years, toxicological 
and chemical databases have expanded substantially, and 
computational methods have been fine-tuned, so that in silico 
approaches to toxicity assessment now appear feasible and 
highly suitable (Knudsen et al., 2013; Kongsbak et al., 2014). 
The U.S. EPA (Knudsen et al., 2013) and a National Research 
Council expert committee (NRC, 2007) has recommended that 
in silico approaches should be included in future assessments 
of toxicity with the aim to reduce and refine existing methods. 
While in silico computer simulations cannot substitute biolog-
ical testing, they can help focus on particular substances and 
targets to allow priority setting for more efficient testing. Over-
all, computational approaches can reduce animal experiments 
according to the 3R definition (Replacement, Reduction, Re-
finement). 
Computational systems biology studies have shown up 
links between chemicals and diseases such as between the 
pesticide dichlorodiphenyltrichloroethane (DDT) and type 
II diabetes (Audouze and Grandjean, 2011), and between 
persistent organic pollutants (POPs) and metabolic diseases 
(Ruiz et al., 2016). However, the area has not been systemat-
ically screened, and environmental factors are rarely consid-
ered when creating disease-disease networks. Investigations 
reported in this area to date include a chemical-disease infer-
ence system based on chemical-protein interactions, Chem-
DIS, which was created with the aim to predict potential 
health risks associated with chemicals (Tung, 2015). Further, 
environmental etiological factors and genetic factor associa-
tions have been described using Medical Subject Headings 
(MeSH) terms (Liu et al., 2009). Also, a recent study has 
developed an integrated disease network based on various 
heterogeneous data types including disease-chemical associ-
ations (Sun et al., 2014b). Although interesting, such models 
are usually limited to binary data (chemical linked or not 
linked to a disease) and do not take into account the degree 
of the associations. For example, the severity of the chemical 
toxicity is rarely considered in a network-based approach 
and integration of such information would be valuable in the 
interpretation of the model outcomes.
In the present study, our main objective was to create a hu-
man environmental disease network (EDN) based on chem-
ical-disease information from a comprehensive resource of 
chemicals and diseases, the Collaborative on Health and the 
Environment Toxicant and Disease Database (TDDB)1. This 
database compiles existing information between chemical 
contaminants and approximately 200 human diseases based 
on biological and epidemiological evidence. Interestingly, it 
includes a level of evidence (from limited to good) between 
chemicals and diseases to estimate how the chemical expo-
sure could contribute to the diseases. For example, mercury 
1 http://www.healthandenvironment.org/tddb
2 http://monographs.iarc.fr/ENG/Classification/
3 https://oehha.ca.gov/
4 http://www.epa.gov/ttnatw01/toxsource/carcinogens.html
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significance level of 0.05 after Bonferroni correction for mul-
tiple testing was used to select the most relevant associations. 
Predicting novel chemical-disease links
To predict diseases potentially linked to a chemical, a neighbor 
disease approach was performed based on the neighbor protein 
procedure described previously (Audouze et al., 2010). This 
approach is a multi-step procedure. First, diseases associated 
with the chemicals of interest from the TDDB database are 
listed. These input diseases allow identifying network(s) sur-
rounding them by using the network-neighbor’s pull down 
approach (de Lichtenberg et al., 2005). In this procedure, the 
SE-EDN was queried for the input diseases, and associations 
between these were added. Next, the first order interactors of 
all input diseases were queried and added. A score was calcu-
lated for each neighbor, taking into account the topology of 
the surrounding network based on the ratio between total as-
sociations and associations with input diseases. Diseases with 
a score higher than the threshold (0.1), as defined previously, 
were kept in the final sub-network(s). This node inclusion 
parameter is at the conservative end of the optimal range for 
disease-disease interaction networks. Finally, within the aim 
to select all diseases’ neighbors, all diseases in the network(s) 
were checked for associations among them, and the missing 
ones were added. A confidence score was established by test-
ing each network for enrichment on the input set by comparing 
them against 1.0e-4 random networks. The individual disease 
score was used to rank them, allowing prediction of diseases 
potentially linked to the chemical. 
3  Results
3.1  Generating an environmental 
disease network (EDN)
Based on chemical-disease associations extracted from the 
TDDB database, we constructed a human EDN using the three 
levels of evidence, i.e., SE, GE and LE. An overview of the 
strategy is shown in Figure 1. In total, the resulting EDN con-
sists of 6258 associations between 196 diseases. The SE level 
contains 125 interconnected diseases, the GE level 141 diseases 
and the LE level 138 diseases. To reduce noise and select the 
most significant associations, we assigned a probabilistic score 
(pS) with each disease-disease association represented by the 
weight of each link.
3.2  Mining the environmental disease network
To simplify interpretation, each disease was classified into 19 
primary disorder classes following the classification scheme 
described in the human disease network (Goh et al., 2007) 
(see Tab. S1, https://doi.org/10.14573/altex.1607201s). The 
classification is based on the biological systems affected by the 
diseases. For example, 32 diseases belong to a “cancer” class, 
25 diseases constitute a “respiratory” class and only one disease 
represents the metabolism class. Interaction of two diseases be-
longing to the same class is defined as intra-class. Interaction of 
complete repository of chemicals associated with human dis-
eases with evidence information.
Generating a high confidence human disease-disease network
The relevant chemical-disease links collected from the TDDB 
database were used to generate the disease-disease network. 
Taking all the information into account, the maximum number 
of diseases associated with a group of chemicals, i.e., pesti-
cides, is 99, and the maximum number of chemicals associated 
with one disease, i.e., fetotoxicity, is 70. Looking only at the 
SE layer, the highest number of diseases (17 diseases) is linked 
to lead, and the highest number of chemicals (17 chemicals) 
is associated with the disease hepatitis. The EDN was created 
by representing each disease as a node, and linking any dis-
ease-disease pair for which at least one overlapping chemical 
was identified by an edge. The disease-disease pairs were con-
verted into a non-redundant list of associations to develop our 
model, i.e., if diseases A and B are linked, the network may 
have two associations A-B and B-A. In our approach, only one 
of these pairs was retained to create the EDN.
Probabilistic score
To reduce noise and select the most significant disease-disease 
associations for prediction, we assigned a probabilistic score 
to each generated disease-disease pair. This score is based on 
the probability that a chemical linked to a disease A will also 
affect the other disease B. The diseases are represented by D1, 
D2, … Dn.
For each disease, a set of chemicals is associated:
Chemx := { c ∈ Chemicals|c is associated with Dx }
This probabilistic score (pS) between a pair of diseases is cal-
culated by the following equation:
The pS score increases with the strength of the association.
Exploration of the biological mechanisms: biological  
enrichment
To identify biological outcomes potentially related to individ-
ual chemicals, we first extracted known interactions between 
genes/proteins and chemicals using existing resources of infor-
mation such as the ChemProt database (Kjærulff et al., 2013). 
Then, diseases and gene ontology (GO) information were in-
tegrated from two different sources in each gene/protein list. 
Gene-disease associations were extracted from the GeneCards 
database (March 2015), a comprehensive resource providing 
information on human genes and selected gene-related knowl-
edge, such as functional and disease information (Safran et al., 
2010). To investigate the GO information, all three GO catego-
ries, i.e., (a) molecular function, (b) biological processes, and 
(c) cellular components, were taken into consideration (Gene
Ontology Consortium, 2015).
Diseases and GO terms enrichment analysis were finally 
performed with the gene’s list for each analyzed chemical us-
ing a statistical test based on a hypergeometric distribution. A 
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explain the prominence of these diseases here. Two other classes 
are significantly represented in the SE, which are the develop-
mental and the neurological classes (with 64% and 47% of the 
diseases). Among the top inter-class associations, we retrieved 
links between neurological diseases (cognitive impairment) and 
developmental disorders (low birth weight). 
The two others layers, GE (Fig. S1, https://doi.org/10.14573/
altex.1607201s) and LE (Fig. S2, https://doi.org/10.14573/
altex.1607201s) show complementary information to the SE 
layer. The GE layer shows intra-class associations (coronary ar-
tery disease and hypertension, both being cardiovascular disor-
ders), as well as inter-class links between reproductive and the 
developmental classes. In the GE layer, 2221 associations are 
displayed between 141 diseases. Among the most significant 
associations, ADHD is connected to color vision disturbance. 
Such links are supported by published studies, indicating that 
exposure to heavy metals may impair development of visual 
processing (Ethier et al., 2012). 
The LE layer contains 3604 associations between 138 dis-
eases. The most significant associations in this level are in-
tra-class, and most of them concern cancer (breast cancer-lung 
cancer). For example, association is found between breast can-
cer and abnormal sperm, which is not surprising as both disor-
ders have been suggested to be linked to several environmental 
chemicals (Reed et al., 2007). Overall, only few overlaps are 
retrieved, such as fetotoxicity and low birth weight, cognitive 
impairment and ADHD (significant associations). 
To demonstrate the potential of these networks for the pre-
diction of new disease-disease interactions, a case study with 
type II diabetes is described below.
two diseases from two different classes is defined as inter-class. 
When a disease affects several biological systems, only one 
class is assigned to the disease, based on the system known to 
be the most affected. Therefore, each disease is annotated to 
only one of the 19 classes.
Altogether, the EDN displays intra- and inter-class connec-
tions between 196 diseases. For example, Attention Deficit 
and Hyperactivity Disorder (ADHD) is connected to cogni-
tive impairment, behavioral problems, low birth weight and 
fetotoxicity. Previous studies have shown association between 
prenatal mercury exposure and neuro-developmental disorders 
as behavioral diseases (Grandjean et al., 2014; Bellanger et al., 
2015). This suggests that the environmental origins of diseases 
may be shared between diseases due to similar mechanisms of 
action of chemicals in complex disorders. 
In a second step, we decided to explore the three levels of ev-
idence on the EDN independently to evaluate the ability of the 
proposed approach to connect diseases according to these levels. 
In the SE layer, 125 diseases among the 196 appear connected 
via 1274 interactions. Figure 2 indicates that diseases in the SE 
layer tend to cluster by disease categories, except for cancer 
disorders, which are spread all over in the network. Not surpris-
ingly, some well-known diseases are retrieved among the top in-
tra-class associations, e.g., asthma-rhinitis; abnormal sperm-re-
duced male fertility; bronchitis chronic-chronic obstructive 
pulmonary disease (COPD); ADHD-cognitive impairment. The 
cancer-related disorders and the respiratory diseases appear to be 
the predominant classes including, respectively, 78% and 88% of 
the diseases involved in the EDN. The number of epidemiolog-
ical studies performed on cancers and respiratory disorders may 
Fig. 1: Workflow of the proposed system’s 
chemical biology strategy for predicting 
disease-disease and chemical-disease 
associations
Information on chemicals known to be linked 
to diseases and their evidence levels were 
extracted from the TDDB database and 
cleaned. The EDN model was then created 
using these data based on a protein-protein 
association network procedure, assuming that 
two nodes (i.e., diseases) are connected to 
each other if they share at least one chemical 
for which causal evidence is associated with 
both diseases. A probabilistic score was 
assigned to each disease pair in order to rank 
them. The higher the score, the stronger the 
association is. Using a network-neighbor’s 
pull down procedure, prediction of connection 
between chemical and disease was performed.
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system, such as abnormal sperm and reduced male fertility, 
are linked via polychlorinated biphenyl compounds (PCBs). 
Studies have shown that T2D may affect male reproductive 
functions at multiple levels, including diminished sperm qual-
ity (Jangir and Jain, 2014). These hypotheses are also well in 
line with results provided by newly established computational 
tools. For example, HExpoChem, which allows prediction 
of diseases from chemical exposure (Taboureau et al., 2013) 
links the chemical PCB 126 to hypospadias via a protein com-
plex of FGF9 (p = 0.043). On the ChemDis webserver (Tung, 
2015), the association between PCB 126 and diabetes mellitus 
3.3  Case study: Type II diabetes
EDN exploration: prediction of T2D-disease associations
With the increasing number of diabetic people including chil-
dren and young persons of reproductive age worldwide, there 
is a need to better understand potential secondary effects of the 
disease. To identify potential comorbidities between T2D and 
other diseases, we explored each level of the EDN independent-
ly. The three levels provided different information (Fig. 3). 
In the LE layer, we can see associations between T2D 
and disorders of the reproductive system and hypertension. 
Associations between T2D and diseases of the reproductive 
Fig. 2: Representation of the top significant disease-disease associations based on the probabilistic score using the strong level 
of evidence (SE)
Each node corresponds to a unique disease, colored according to the biological system (class) to which it belongs. The names of the 
19 systems are shown on the right. Nodes’ sizes are determined by the number of chemicals linked to the disease with a strong level 
of evidence. An edge is placed between two diseases if they share at least one chemical within the SE level. The width of an edge is 
proportional to the number of chemicals that are linked to both diseases. For example, six chemicals are linked with both myocardial 
infarction and arrhythmias disorders, resulting in an edge with a probabilistic score of 0.26. For reasons of clarity, only the top significant 
associations (based on the calculated score) are shown.
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(Grondin et al., 2016), these two diseases have 28 common 
genes and 42 common chemicals including PCBs (informa-
tion from curated data), suggesting a potential similarity in the 
mechanism of action.
Fewer associations were identified in the two other layers 
(SE and GE). For example, a link between T2D and Hodgkin’s 
disease (HD) is indicated via endocrine disruptor chemicals 
in GE (Fig. 3). This association is supported by a study that 
has examined epidemiological associations between T2D and 
the risk of HD, and concluded that the diseases may be linked 
(Mitri et al., 2008). The incidence of both T2D and HD has 
increased significantly during the past decades, and a study on 
a population-based cohort of more than 130 000 adults sug-
gests that T2D may be associated with an increased risk of 
developing HD (Yang et al., 2016).
Hormonal changes and T2D are also predicted to be con-
nected via two levels of the EDN (GE and LE). From a sys-
tems chemical biology perspective, T2D is linked to hormonal 
is statistically inferred from a chemical-protein-disease rela-
tionship (p = 1.98e-2).
Regarding the association of T2D and hypertension, pub-
lished studies have supported a substantial overlap between 
T2D and hypertension in etiology and disease mechanisms 
(Gress et al., 2000; Cheung and Li, 2012). This interaction has 
been observed in diabetic patients who presented hypertension 
symptoms (Jensen et al., 2012). In our approach, both diseas-
es are connected by exposure to PCBs. It has been reported 
independently that PCBs may increase insulin resistance, 
cause T2D (Kouznetsova et al., 2007) and are associated with 
hypertension (Everett et al., 2008). However, the underlying 
mechanism(s) remains to be ascertained. Using HExpoCHem, 
PCB 126 was associated, though not statistically significant-
ly, with insulin sensitivity via a protein complex of ADIPOQ 
(p > 0.05), and with arterial hypertension via a protein com-
plex of AGTR1 and another complex of NOS3 (both p > 0.05). 
According to the Chemical Toxicogenomics Database (CTD) 
Fig. 3: Full prediction of T2D-disease associations within the three levels of evidence
To identify potential comorbidities between T2D and other diseases, each level of the EDN was independently explored, providing different 
information. Each biological system is depicted by a specific color indicating to which class a disease belongs.
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genes, 162 were linked to regulation of hormone secretion. 
14 of them are associated with TCDD, giving a p = 3.361e-11. 
Another GO process, response to steroid hormone stimulus 
(294 genes among the 14,650), shows also a significant p-val-
ue of 0.032 via 9 genes linked to TCDD. So, we can see that 
several genes linked to TCDD are present in T2D and hormon-
al changes (Tab. 1). 
Regarding potential links between DDT and T2D, 16 genes 
associated with DDT were known to be linked to diabetes 
mellitus in the disease database. After enrichment, DDT was 
significantly associated to steroid hormone receptor activity 
via 10 genes (p = 1.596e-05) based on information from the 
GO function, which contains 15,209 genes (Tab. 1). Overall, 
these analyses support the findings linking T2D and hormonal 
changes identified by exploring the GE levels on the EDN. 
3.4  Deciphering possible links between 
novel chemicals and disease 
Besides revealing connections between diseases, the EDN can 
be used to assess the risk of a chemical to induce diseases. 
As chemicals may interact with several proteins or protein 
complexes (Paolini et al., 2006), and diseases may also be 
connected to multiple proteins, this approach can be helpful 
to identify potential relationships between chemicals and dis-
eases. We therefore developed and applied a neighbor disease 
changes via 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD) (GE 
layer) and dichlorodiphenyltrichloroethane (DDT) (LE layer). 
Recent computational studies have explored possible patho-
genetic links between environmental chemicals and diseases 
through various data types, such as genome-wide associations 
and disease similarities, and found a potential link between 
both T2D and TCDD, and T2D and DDT (Audouze and 
Grandjean, 2011). 
The EDN also shows that dermatological disorders may be 
linked to T2D (SE level), which is not surprising as skin com-
plications related to T2D are common. 
Exploration of the biological mechanisms: understanding  
the findings for T2D-disease predictions
To gain a better comprehension of the predicted associations 
between T2D and hormonal changes and decipher a possible 
biological relevance, we went one step further. We performed 
biological enrichment in order to suggest potential mode(s) of 
action of the two chemicals (TCDD and DDT) to understand 
their connections to both disorders. To identify biological out-
comes, disease and GO enrichments were done on the protein 
lists extracted from the ChemProt database for TCDD and DDT. 
In the disease database, 206 genes were connected to T2D. 
Among them, 26 are perturbed by TCDD, giving a significant 
adjusted p = 1.904e-19. From the GO process, among the 14,650 
Tab. 1: Biological enrichment for 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD) and dichlorodiphenyltrichloroethane (DDT) 
Diseases from the GeneCards databases and Gene Ontologies (GO) terms were considered. Bonferroni corrected p-values  
and the genes associated with diseases and GO terms are listed by HUGO gene symbol. 
Chemical Biological Enrichment No. of genes p-value Gene list
TCDD Disease Diabetes mellitus 26 1.90e-19 CPT1A; EDN1; AKT2; GCK; HMOX1; HNF4A; HP; IRS1;  
KCNJ11; LEP; LEPR; NFKB1; ENPP1; PPARA; PPARG;  
RETN; PTPN1; SLC2A1; SLC2A2; SLC2A4; TNFRSF1A;  
C3; UCP2; WFS1; CAT; ADIPOQ
GO process regulation of 14 3.36e-11 CPT1A; EDN1; GCK; HNF4A; IL6; IRS1;  
hormone secretion KCNJ11; LEP; SLC2A1; SLC2A2; HNF1A; TCF7L2; IRS2;  
(go:0046883) ADIPOQ
response to steroid 9 0.032 EDN1; HMOX1; FAS; IL6; KCNJ11; PPARA; PPARG;  
hormone stimulus TNFRSF1A; ADIPOQ  
(go:0048545)
DDT Disease Diabetes mellitus 16 0.799 ADRB3; ESR2; ALB; G6PD; GGT1; GPT; IL1R1; NFKB1;  
PON1; MAPK8; RBP4; SHBG; SOD1; TNFRSF1A; CAT;  
PDE5A
GO process steroid hormone 10 1.59e-05 NR0B1; ESR1; ESR2; HNF4G; AR; PGR; RXRB; NR0B2;  
receptor activity NR1I2; NR1I3 
(go:0003707)
hormone activity 4 n.s.* FSHB; GNRH1; POMC; TSHB 
(go:0005179)
* n.s., non-significant
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that BPA mimics estrogens in the body and might be associated 
with putative markers of breast cancer risk (McGuinn et al., 
2015). Until now, no direct epidemiological associations exist, 
but it could well contribute as it affects the genes that defend 
against cancer (Bhan et al., 2014). 
A relationship between BPA and behavioral disorders is also 
found in the network. Published studies suggest potential as-
sociations of prenatal/early life BPA exposure with behavior 
problems, including anxiety, depression, and ADHD in chil-
dren (Mustieles et al., 2015; Casas et al., 2015). Also, boys ex-
posed to higher BPA concentrations as a fetus or during early 
childhood were more likely to suffer from anxiety, aggression, 
depression and hyperactivity at age 7 (Harley et al., 2013). 
We looked at chlordane as a second example. Chlordane is 
a pesticide banned in Europe and the US, but very persistent 
in the environment5. Therefore, exposure to chlordane is still 
harming the health of millions of people (Evangelou et al., 
2016). The acute (short-term) effects of chlordane in humans 
consist of gastrointestinal distress and neurological symp-
toms, such as tremors and convulsions (National Library of 
Medicine, 1992). Chronic (long-term) inhalation exposure of 
procedure built on a neighbor protein procedure, which scores 
the associations between diseases, to the EDN model. The per-
formance of this approach has been shown in previous studies 
(Audouze et al., 2010, 2014). Only the SE layer was used. Dis-
eases known to be connected to various chemicals were listed 
independently, i.e., one disease list for each chemical. Each 
disease list was scanned into the disease network in order to 
identify other diseases potentially linked (with a high score) to 
the chemical (Tab. 2).
As a first example, we screened bisphenol A (BPA), which 
is an environmental estrogen used in the manufacture of poly-
carbonate plastics and epoxy resins to make food and beverage 
packaging. The use of BPA in food and beverage packaging 
has been banned in several countries due to its potential toxic 
effects on the reproductive system, and also on hypertension 
and metabolic disorders (Ariemma et al., 2016). The effect of 
BPA exposure on human brain and behavior is a relatively new 
issue, and particular concerns have been raised about its poten-
tial impact on children (Perez-Lobato et al., 2016). Using our 
approach, several diseases were identified as potentially linked 
to BPA (Tab. 2). For example, increasing evidence suggests 
5 Stockholm Convention, UNEP, 2016: http://chm.pops.int/TheConvention/ThePOPs/ListingofPOPs
Tab. 2: Mining the full EDN for diseases associated with bisphenol A (BPA), chlordane and hexachlorobenzene (HCB) 
The number of diseases already known from the database to be associated with the chemical is shown, and the highest and lowest 
probabilistic scores are mentioned with the diseases. Predicted diseases are shown with their corresponding scores. For example,  
BPA is predicted to be connected to eight already known diseases, for which menstrual disorders has the highest score. Moreover,  
BPA is also predicted to be linked to five other diseases, among them leukemia, which has the highest score, and for which there  
is no literature support to date.
Environmental Known Diseases Predicted diseases Score 
exposure (all layers) (max and min score) 
BPA 8 Menstrual disorders (1.65) Leukemia childhood 2.57
Altered time to sexual maturation (0.42) Leukemia adult 2.09
Breast cancer 1.72
Testicular toxicity 1.65
ADD/ADHD 1.30
Chlordane 11 Adult onset leukemia (2.95) Brain cancer childhood 2.65
Peripheral neuropathy (0.17) Brain cancer adult 2.65
Congenital malformation 2.33
Fetotoxicity 1.89
Olfactory alteration 0.48
HCB 15 Brain cancer adult (3.45) Brain cancer child 4.49
Hyperkeratosis (0.08) Skin cancer 3.24
Congenital malformation 3.23
Abnormal sperm 1.77
Lung cancer 1.52
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tion and an extension of the proposed network with integration 
of other data would be beneficial. Some efforts are on-going in 
measuring potential human exposure to environmental chem-
icals and facilitating public access to these data. As examples, 
we can mention the exposure data collection of the U.S. EPA6, 
the human exposome project8, the Heals project, which is the 
largest research project in Europe on environment and health9, 
and the national report on human exposure to environmental 
chemicals by the Centers for Disease Control and Prevention10. 
Still, the TDBB database has the benefit of organizing the 
chemical-disease associations based on three levels of evidence 
that allowed us to develop an environmental disease network 
with a better selectivity than a global network. Developing bi-
ological networks with more selective data allows generating 
more accurate and predictive models. Another advantage of 
the proposed network-based approach is the ability to identify 
potential new chemical-disease relationships without taking 
into consideration the chemical structure as the majority of 
computational tools do in this area.
The next challenge will be to integrate further databases 
suitable for the generation of computational methods able 
to decipher potential risks associated with chemicals and to 
generate hypotheses, accelerating the hazard identification 
process. One way to screen more of the available data would 
be to use advanced text mining tools, such as one used to ex-
tract drug-adverse event information from electronic medical 
records (Roitmann et al., 2014). Crossing the hypotheses made 
by our approach with some other observations described in 
the literature could further improve the characterization of 
potential chemical-disease relationships. For example, a group 
led by Leonardo Trasande has recently developed a system to 
estimate health and economic costs related to endocrine dis-
rupting chemicals (EDCs) exposure in the European Union 
(Trasande et al., 2015, 2016) and the USA (Attina et al., 2016). 
To estimate costs, they used available epidemiological and 
toxicological evidence for each EDC and weighted them. Such 
probability of causation, e.g., EDC causation of IQ loss and 
association with autism, childhood obesity or male infertility, 
could be crossed with other computational models and the 
TDDB database. 
5  Conclusions
Despite all recent advances in high throughput interactome map-
ping and in disease gene identification, both the protein-protein 
interactions and our knowledge of disease associated genes 
remain incomplete (Menche et al., 2015). We present in this 
study a disease-disease network based on a degree of evidence 
from chemical-disease relationships. The ability of the EDN to 
identify novel disease-disease associations and chemical-dis-
humans to chlordane results in effects on the nervous system 
(Kim et al., 2015). Our approach predicts chlordane to have 
an association with brain cancer, which is in line with the U.S. 
EPA classification as a Group B2 probable human carcinogen6. 
Chlordane was also predicted to be associated with olfactory 
alteration. Although a direct olfactory impairment from chem-
ical exposure including pesticides has not been identified, it 
is known that some environmental chemicals may induce re-
spiratory inflammations that cause such damage (Doty, 2015). 
Furthermore, it has been suggested that olfactory loss can occur 
as a result of exposure to chemicals present in air pollution or 
workplace situations (Quandt et al., 2016), but no specific link 
between chlordane and olfactory disorders has been reported.
We finally explored the synthetic industrial chemical hexa-
chlorobenzene (HCB). HCB is a bioaccumulative, persistent 
and toxic pollutant defined by the Stockholm Convention5. 
Historically HCB was commonly used as a pesticide and 
fungicide7. Although HCB production has stopped in many 
countries7, the compound is still generated inadvertently, as a 
byproduct and/or impurity in the manufacture of various chlo-
rinated compounds, and released into the environment (Mrema 
et al., 2012). In our network, HCB is predicted to be associated 
with reproductive disorders such as congenital malformation 
and abnormal sperm. Environmental exposure to endocrine 
disrupting chemicals, including HCB, have been suggested as 
a risk factor for male genital abnormalities such as hypospadi-
as (Rignell-Hydbom et al., 2012; Krysiak-Baltyn et al., 2012). 
A recent study showed for the first time a correlation between 
serum concentration of HCB and semen quality (Paoli et al., 
2015). Regarding its potential links to cancer, these results are 
supported by the International Agency for Research on Cancer 
and the U.S. EPA that classify HCB as a probable human car-
cinogen (U.S. EPA, 1999). 
4  Discussion
The proposed approach offers a network-based hypothesis for 
the emergence of complex diseases, which cannot always be 
explained by genetic variability only, but also may be linked to 
environmental factor exposure.
Although our EDN can be of help in the understanding 
of disease co-occurrences, of mechanisms of action, and in 
the risk assessment of new chemicals, we are aware that the 
chemical-disease annotations used in this work are limited in 
terms of diseases and chemicals. For example, the version of 
the TDBB database used here does not include data on obesity 
or inflammatory bowel diseases. Similarly, the list of contam-
inants is relatively general for some classes of chemicals, e.g., 
air pollution and dusts. Therefore, we considered only a part of 
the currently available information in our EDN based-predic-
6 https://www.epa.gov 
7 Agency for Toxic Substances and Disease Registry - ATSDR report, 2015. https://www.atsdr.cdc.gov
8 http://humanexposomeproject.com/
9 http://www.heals-eu.eu/
10 https://www.cdc.gov/exposurereport/
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ease associations was illustrated by several examples, such as 
the suggestion of links between BPA and ADHD, and chlordane 
and olfactory dysfunction, which would need further investiga-
tions to be confirmed. Such computational methods can be used 
to enhance our current knowledge and may help to prioritize 
further experimental testing.
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